Effect of Tenuigenin on low density lipoprotein receptor-related protein 1 level changes of Alzheimer’s disease rat in hippocampus

NI Jie FANG Yu HU Yan DONG Yu-lin

Acta Anatomica Sinica ›› 2016, Vol. 47 ›› Issue (6) : 744-749.

PDF(466 KB)
Welcome to visit Acta Anatomica Sinica! Today is Chinese
PDF(466 KB)
Acta Anatomica Sinica ›› 2016, Vol. 47 ›› Issue (6) : 744-749. DOI: 10.16098/j.issn.0529-1356.2016.06.004
Neurobiology

Effect of Tenuigenin on low density lipoprotein receptor-related protein 1 level changes of Alzheimer’s disease rat in hippocampus

  • NI Jie1 FANG Yu1 HU Yan DONG Yu-lin 3*
Author information +
History +

Abstract

Objective To observe the effect of Tenuigenin (TEN) on low density lipoprotein receptor-related protein 1(LRP1)level in Alzheimer’s disease (AD) rat hippocampus. Methods Sixty SD rats were randomly divided into groups respectively. β-Amyloid protein (Aβ)1-40 was injected into hippocampus CA1 region to establish AD model by brain stereotactic technique and then rats were treated with intragastric TEN for four weeks. Learning and memory abilities were assessed by Morris water maze and the Real-time PCR and Western blotting were used to analysis the expression of LRP1 mRNA and protein. The changes of LRP1 positive neurons were checked by immunofluorescence staining. Results 1. Morris water maze: the learning and memory ability of the AD group was significantly decreased than that of the normal group(P<0.01).After TEN gastric lavage treatment, the escape latency was shortened, the swimming distance was reduced, and the frequency of the virtual platform was increased in every TEN treatment group, there were a statistically significant difference in middle and high dose group(P<0.05 or P<0.01). 2. Real-time PCR and Western blotting: the relative expression levels of LRP1 mRNA and protein in AD group were significantly lower than that in normal control group (P<0.01). After TEN treatments, the relative expression of LRP1 mRNA and protein in the treatment group increased gradually with the increase of the dosage of TEN. The effect of low dose group was not significant (P>0.05), but there were a significant difference between middle and high dose groups (P<0.01). 3. Compared with normal group, the number of LRP1 positive cells in the AD group decreased significantly (P<0.01), but in the high dose group increased significantly (P>0.05). Conclusion TEN may improve the learning and memory ability of Aβ 1-40induced AD rats by increasing the content of LRP1 in the brain.

Key words

Tenuigenin / Alzheimer’s disease / β\ / Amyloid protein 1-40 / Hippocampus /   / Real-time PCR / Rat

Cite this article

Download Citations
NI Jie FANG Yu HU Yan DONG Yu-lin. Effect of Tenuigenin on low density lipoprotein receptor-related protein 1 level changes of Alzheimer’s disease rat in hippocampus[J]. Acta Anatomica Sinica. 2016, 47(6): 744-749 https://doi.org/10.16098/j.issn.0529-1356.2016.06.004

References

[1]Tu S, Okamoto S, Lipton SA, et al. Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease[J]. Mol Neurodegener, 2014, 9:48. 
[2]Nazem A, Sankowski R, Bacher M, et al. Rodent models of neuroinflammation for Alzheimer’sdisease[J]. J Neuroinflammation, 2015,12:74. 
[3]Carret-Rebillat AS, Pace C, Gourmaud S, et al. Neuroinflammation and Aβ accumulation linked to systemic inflammation are decreased by genetic PKR downregulation[J]. Sci Rep, 2015, 5:8489. 
[4]Ehninger D, Kempermann G. Paradoxical effects of learning the Morris water maze on adult hippocampal neurogenesis in mice may be explained by a combination of stress and physical activity[J]. Genes Brain Behav, 2006, 5(1):29-39. 
[5]Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR[J]. Nucleic Acids Res, 2001, 29(9):e45.
[6]de Leon MJ, Convit A, DeSanti S, et al. Contribution of structural neuroimaging to the early diagnosis of Alzheimer’s disease[J]. Int Psychogeriatr, 1997, 9 Suppl 1:183-190, discussion 247-252.
[7]Sigurdsson EM, Lorens SA, Hejna MJ, et al. Local and distant histopathological effects of unilateral amyloid-beta 25-35 injections into the amygdala of young F344 rats[J]. Neurobiol Aging, 1996, 17(6):893-901.
[8]Delobette S, Privat A, Maurice T. In vitro aggregation facilities beta-amyloid peptide-(25-35)-induced amnesia in the rat[J]. Eur J Pharmacol, 1997, 319(1):1-4.
[9]Giovannelli L, Casamenti F, Scali C, et al. Differential effects of amyloid peptides beta-(1-40) and beta-(25-35) injections into the rat nucleus basalis[J]. Neuroscience, 1995, 66(4):781-792.
[10]Sajan FD, Martiniuk F, Marcus DL, et al. Apoptotic gene expression in Alzheimer’s disease hippocampal tissue[J]. Am J Alzheimers Dis Other Demen,2007,22(4):319-328. 
[11]Nakamura S, Murayama N, Noshita T, et al. Cognitive dysfunction induced by sequential injection of amyloid-beta and ibotenate into the bilateral hippocampus; protection by memantine and MK-801[J]. Eur J Pharmacol, 2006, 548(1-3):115-122. 
[12]Ikeya Y, Takeda S, Tunakawa M, et al. Cognitive improving and cerebral protective effects of acylated oligosaccharides in Polygala tenuifolia[J]. Biol Pharm Bull, 2004, 27(7):1081-1085. 
[13]Turdi S, Guo R, Huff AF, et al. Cardiomyocyte contractile dysfunction in the APPswe/PS1dE9 mouse model of Alzheimer’s disease[J]. PLoS One, 2009, 4(6):e6033. 
[14]Castellano JM, Deane R, Gottesdiener AJ, et al. Low-density lipoprotein receptor overexpression enhances the rate of brain-to-blood Abeta clearance in a mouse model of beta-amyloidosis[J]. Proc Natl Acad Sci USA, 2012, 109(38):15502-15507. 
[15]Sagare AP, Deane R, Zlokovic BV. Low-density lipoprotein receptor-related protein 1: a physiological Abeta homeostatic mechanism with multiple therapeutic opportunities[J]. Pharmacol Ther, 2012, 136(1):94-105.

PDF(466 KB)

Accesses

Citation

Detail

Sections
Recommended

/